|
LSM14B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.277600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.881800E-02 |
| Normal-vs-Stage2 |
8.137400E-01 |
| Normal-vs-Stage3 |
2.062300E-03 |
| Normal-vs-Stage4 |
1.175210E-01 |
| Stage1-vs-Stage2 |
3.808000E-02 |
| Stage1-vs-Stage3 |
1.522240E-01 |
| Stage1-vs-Stage4 |
8.615800E-01 |
| Stage2-vs-Stage3 |
9.699800E-03 |
| Stage2-vs-Stage4 |
1.369600E-01 |
| Stage3-vs-Stage4 |
2.146400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.299780E-02 |
| Normal-vs-AfricanAmerican |
4.715000E-01 |
| Normal-vs-Asian |
4.736100E-02 |
| Caucasian-vs-AfricanAmerican |
1.928270E-02 |
| Caucasian-vs-Asian |
9.632800E-01 |
| AfricanAmerican-vs-Asian |
5.778000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.904240E-01 |
| Normal-vs-Female |
2.695500E-02 |
| Male-vs-Female |
2.680200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.260400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.505900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.408620E-01 |
| Normal-vs-Age(81-100Yrs) |
1.283360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.165800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.119000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.221000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.147800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.282800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.270800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.400470E-03 |
| Classical-VS-Follicular |
9.935700E-02 |
| Classical-VS-Other |
6.719200E-01 |
| Classical-VS-Normal |
5.652300E-02 |
| Tall-VS-Follicular |
1.647230E-04 |
| Tall-VS-Other |
2.242400E-01 |
| Tall-VS-Normal |
1.034270E-04 |
| Follicular-VS-Other |
8.625400E-01 |
| Follicular-VS-Normal |
7.815800E-01 |
| Other-VS-Normal |
7.283800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.747900E-02 |
| Normal-vs-N1 |
1.584520E-03 |
| N0-vs-N1 |
4.749500E-02 |
|
|
